Advanced search
1 file | 778.64 KB

The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy

(2011) LARYNGOSCOPE. 121(2). p.335-338
Author
Organization
Abstract
This report describes cartilaginous regeneration in a cricoarytenoid joint affected by spondyloarthropathy using tumor necrosis factor-alpha (TNF-alpha) blockade, monitored by magnetic resonance (MR) and computed tomography (CT) imaging. This case is interesting for several reasons. It is only the eighth case of destructive ankylosing spondylitis-related cricoarytenoid arthritis published in the English language literature. It describes, for the first time, full recovery of vocal cord mobility following TNF-alpha blockade. It is also the first case to be published with MR imaging demonstrating regeneration of the cricoarytenoid cartilage following treatment. This case represents a landmark in the treatment of patients presenting with destructive arthritis involving the cricoarytenoid joint.
Keywords
RHEUMATOID-ARTHRITIS, JOINTS, Laryngology

Downloads

    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 778.64 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Desuter, Gauthier, Thierry Duprez, Caroline Huart, Quentin Gardiner, and August Verbruggen. 2011. “The Use of Adalimumab for Cricoarytenoid Arthritis in Ankylosing Spondylitis: An Effective Therapy.” Laryngoscope 121 (2): 335–338.
APA
Desuter, G., Duprez, T., Huart, C., Gardiner, Q., & Verbruggen, A. (2011). The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy. LARYNGOSCOPE, 121(2), 335–338.
Vancouver
1.
Desuter G, Duprez T, Huart C, Gardiner Q, Verbruggen A. The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy. LARYNGOSCOPE. 2011;121(2):335–8.
MLA
Desuter, Gauthier, Thierry Duprez, Caroline Huart, et al. “The Use of Adalimumab for Cricoarytenoid Arthritis in Ankylosing Spondylitis: An Effective Therapy.” LARYNGOSCOPE 121.2 (2011): 335–338. Print.
@article{1975360,
  abstract     = {This report describes cartilaginous regeneration in a cricoarytenoid joint affected by spondyloarthropathy using tumor necrosis factor-alpha (TNF-alpha) blockade, monitored by magnetic resonance (MR) and computed tomography (CT) imaging. This case is interesting for several reasons. It is only the eighth case of destructive ankylosing spondylitis-related cricoarytenoid arthritis published in the English language literature. It describes, for the first time, full recovery of vocal cord mobility following TNF-alpha blockade. It is also the first case to be published with MR imaging demonstrating regeneration of the cricoarytenoid cartilage following treatment. This case represents a landmark in the treatment of patients presenting with destructive arthritis involving the cricoarytenoid joint.},
  author       = {Desuter, Gauthier and Duprez, Thierry and Huart, Caroline and Gardiner, Quentin and Verbruggen, August},
  issn         = {0023-852X},
  journal      = {LARYNGOSCOPE},
  keyword      = {RHEUMATOID-ARTHRITIS,JOINTS,Laryngology},
  language     = {eng},
  number       = {2},
  pages        = {335--338},
  title        = {The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis: an effective therapy},
  url          = {http://dx.doi.org/10.1002/lary.21343},
  volume       = {121},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: